‘What is health?’ and KHN: Funding for new disease

Can’t find the microphone? Click here to listen to Acast. You can listen on Spotify, Apple Podcasts, Stitcher, Pocket Casts, or anywhere you listen to podcasts.

President Joe Biden released his 2023 funding proposal this week, calling for a nearly 27% increase in funding for the Department of Health and Human Services. It has $ 28 billion for the Centers for Disease Control and Prevention to implement a preparedness program for future illnesses and $ 40 billion for HHS to spend on the production of vaccines and drugs. other treatments.

In addition, the FDA and CDC have approved a double booster shot for most people 50 and over. But federal officials give little advice to consumers about what that shot is and when.

This week’s panelists include Mary Agnes Carey of KHN, Amy Goldstein of The Washington Post, Jennifer Haberkorn of the Los Angeles Times, and Rachana Pradhan of KHN.

Among the excerpts from this week’s event:

  • Biden’s advice on preparing money for an upcoming disease reinforces his sense of urgency in improving the health care industry, but Congress is unlikely to take that path. Now, some lawyers say the government is asking for more money to help fund more covid-19 testing and cannabis operations.
  • A bipartisan group of senators met in recent days hoping to get a permit to return the money for probation and probation. Republicans complained that the first aid was not used for covid and that there was not enough information about where it went. They want to get back some of the money they lost. There has been no indication that the group of senators is planning to move forward, but the upcoming spring break for Easter and Easter could provide an opportunity to help debate.
  • The leader previously sought more than $ 20 billion for testing and vaccines. Congress is ready to spend about $ 15 billion before hitting the impasse. Some reports suggest that Senate negotiators are talking about $ 10 billion, which could be funded in just a few months.
  • The Centers for Medicare & Medicaid Services also announced this week that a new review shows that health care growth in the U.S. has slowed.
  • Millions of Americans are expected to lose Medicaid coverage once the covid crisis is over and states can leave those who do not meet the necessary requirements. Proponents note that some of these people will not move to other claimant options, such as insurance offered in the Affordable Care Act insurance markets.
  • A major role of the ACA is to help lower health costs, and the law has created a new employment center to fund programs that are looking for ways to work. Experts at the time believed that economic management could change, and the center acted as a guide in its research. But there is little evidence now that such practices produce serious consequences.

Also this week, Julie Rovner interviewed KHN’s Julie Appleby, who presented and wrote the latest KHN-NPR “Bill of the Month” about an airplane car. If you have an awesome medical pill that you would like to share with us, you can do so here.

In addition, for additional credit, the panelists share their favorite health policy history of the week that they hope to read as well:

About Mary Agnes Carey: The New Yorker “Forty -Three Years of a Freelancer in the American Health Care System,” by David Owen

Amy Goldstein: Stat’s “NIH’s Identity Crisis: The Pandemic and The Search for a New Leader Leaving Office on the Road,” by Lev Facher

Jennifer Haberkorn: The New York Times “FDA rushed to a drug for firstborns. Did it put speed on science?” and Christina Jewett

Rachana Pradhan: The Washington Post “‘ Is This What a Good Mother Is? ’” By William Wan

Also discussed in this week’s podcast:

The Wall Street Journal’s “You May Not Need Four Covid Shots,” by Philip Krause and Luciana Borio.

To listen to our full podcasts, click here.

And subscribe to KHN’s What the Health? on Spotify, Apple Podcasts, Stitcher, Pocket Casts or wherever you listen to podcasts.

Related topics

Contact us Submit a story comment

Related Posts

Leave a Reply

Your email address will not be published.